MiFID II Research Fees – Most are going to take to P&L – See the Latest List

Below is a the latest list of who’s planning on doing what with the research fees. More and more firms are confirming that they’ll be taking the fees to P&L with the RPA route becoming increasing unpopular within the UK. This is not a surprise given the knock on ramifications of taking the RPA approach.

The OCREUS Group have their own independant views, opinions and advisory paper on this matter which some firms have used as part of their thought process.

Take to P&L RPA Undecided
Allianz Global Investors Amundi Ashmore
Aviva Investors BNY Mellon
Axa Investment Management Carmignac Candriam
Baille Gifford Deka GAM
Barlings Fidelity Interational Lyxor
Blackrock
BlueBay Asset Management
BNP Parisbas
Brewin Dolphin
Brooks Macdonald
Canada Life
Charles Stanley
Deutche Asset Management
Evenlode
Equitile
Flossbach von Storch
Franklin Templeton
Goldman Sachs Asset Management
Hernes
HBSC Global Asset Management
Insight Investment
Invesco
Janus Henderson
JO Hambro
JP Morgan Asset Management
Jupiter
Kempen Capital Management
Legal & General Investment Management
Man Group
M&G Investment
Majedie Asset Management
Morgan Stanley
Natixis Global Asset Management
MN Investments Partners
Newton Investment Management
Nordea
Northern Trust Asset Management
Old Mutual Global Investors
Pictet
Pimco
Rathbones
RBC
Robeco
Royal London
Russell Investment
Schroders
Seven Investment
Standard Life Aberdeen
Stwewart Investors
SVM
T Rowe Price
Troy Asset Management
Twenty Four Asset Management
UBS
Unigestion
Union Investmenet
Vanguard
Woodford Investmenet Management
Data at of 22nd November 2017
Source – FT research